TARA · Company research
Protara Therapeutics, Inc. Common Stock (TARA): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
17records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| About 80% of U.S. adults who rely on nutrition through a vein lack choline. Protara enrolled 24 in its study. - Stock Titan | About 80% of U.S. adults who rely on nutrition through a vein lack choline. Protara enrolled 24 in its study. Stock Titan | View source ↗ | Stock Titan | Oct 15, 2026 | neutral | 0 | 0.6 |
| Protara Therapeutics (NasdaqGM:TARA) Stock Forecast & Analyst Predictions - Simply Wall Street | Protara Therapeutics (NasdaqGM:TARA) Stock Forecast & Analyst Predictions Simply Wall Street | View source ↗ | Simply Wall Street | Oct 5, 2026 | neutral | 0 | 0.6 |
| Datadog, Zscaler Lead Fresh Software Stock Selloff As AI Fears Return, But Analysts Call It Overdone - Stocktwits | Datadog, Zscaler Lead Fresh Software Stock Selloff As AI Fears Return, But Analysts Call It Overdone Stocktwits | View source ↗ | Stocktwits | Oct 4, 2026 | neutral | 0 | 0.6 |
| Protara Therapeutics, Inc. Stock Price Prediction: Today, Tomorrow, Next Week (TARA) - Traders Union | Protara Therapeutics, Inc. Stock Price Prediction: Today, Tomorrow, Next Week (TARA) Traders Union | View source ↗ | Traders Union | Sep 30, 2026 | neutral | 0 | 0.6 |
| A founder sells 4.6 million shares for about C$32.8 million at Xanadu - Stock Titan | A founder sells 4.6 million shares for about C$32.8 million at Xanadu Stock Titan | View source ↗ | Stock Titan | Sep 22, 2026 | neutral | 0 | 0.6 |
| IDEX Corp Officer Tara M. Tereso Sells 290 Shares in Tax-Related Stock Transaction - Kalkine Media | IDEX Corp Officer Tara M. Tereso Sells 290 Shares in Tax-Related Stock Transaction Kalkine Media | View source ↗ | Kalkine Media | Sep 18, 2026 | neutral | 0 | 0.6 |
| Protara’s TARA-002 Moves Into Pivotal Bladder Cancer Trial: What Investors Should Watch - TipRanks | Protara’s TARA-002 Moves Into Pivotal Bladder Cancer Trial: What Investors Should Watch TipRanks | View source ↗ | TipRanks | Aug 20, 2026 | neutral | 0 | 0.6 |
| Protara Posts $21.7 Million Q2 Loss as Pipeline Milestones Near | TARA Stock News - Quiver Quantitative | Protara Posts $21.7 Million Q2 Loss as Pipeline Milestones Near | TARA Stock News Quiver Quantitative | View source ↗ | Quiver Quantitative | Aug 11, 2026 | neutral | 0 | 0.6 |
| Protara Therapeutics: Orphan Drug Indications Drive A Heavily Undervalued Pipeline - Seeking Alpha | Protara Therapeutics: Orphan Drug Indications Drive A Heavily Undervalued Pipeline Seeking Alpha | View source ↗ | Seeking Alpha | Aug 11, 2026 | neutral | 0 | 0.6 |
| What Makes Protara Therapeutics (TARA) a New Buy Stock - Yahoo Finance | What Makes Protara Therapeutics (TARA) a New Buy Stock Yahoo Finance | View source ↗ | Yahoo Finance | Jul 21, 2026 | neutral | 0 | 0.6 |
| Should I buy Protara Therapeutics (TARA) - Zacks Investment Research | Should I buy Protara Therapeutics (TARA) Zacks Investment Research | View source ↗ | Zacks Investment Research | Jul 21, 2026 | neutral | 0 | 0.6 |
| TARA Forecast — Price Target — Prediction for 2027 - TradingView | TARA Forecast — Price Target — Prediction for 2027 TradingView | View source ↗ | TradingView | Jun 25, 2026 | neutral | 0 | 0.6 |
| Tradeweb Markets (TW) Stock Could Be 24.6% Undervalued After TARA Launch - Yahoo Finance | Tradeweb Markets (TW) Stock Could Be 24.6% Undervalued After TARA Launch Yahoo Finance | View source ↗ | Yahoo Finance | Jun 16, 2026 | neutral | 0 | 0.6 |
| Cantor Fitzgerald reiterates Protara Therapeutics stock rating - Investing.com | Cantor Fitzgerald reiterates Protara Therapeutics stock rating Investing.com | View source ↗ | Investing.com | May 20, 2026 | neutral | 0 | 0.6 |
| Does TARA Stock’s 15% After-Hours Slump Signal A Bargain After New Bladder Cancer Data? - Stocktwits | Does TARA Stock’s 15% After-Hours Slump Signal A Bargain After New Bladder Cancer Data? Stocktwits | View source ↗ | Stocktwits | Feb 24, 2026 | neutral | 0 | 0.6 |
| TARA-002 results send Protara shares upwards - The Pharma Letter | TARA-002 results send Protara shares upwards The Pharma Letter | View source ↗ | The Pharma Letter | Feb 24, 2026 | neutral | 0 | 0.6 |
| Protara Therapeutics, Inc. Common Stock (TARA) Stock Price: Oct 16 Close $2.32 - Gotrade | Protara Therapeutics, Inc. Common Stock (TARA) Stock Price: Oct 16 Close $2.32 Gotrade | View source ↗ | Gotrade | Jan 13, 2026 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.